Li Wei
- Epidemiology top 10%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Physiology top 10%
- Surgery
- Topics
- Liver Disease Diagnosis and Treatment (5 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers)Glycosylation and Glycoproteins Research (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Wei
40 papers receiving 917 citations
Peers
Comparison fields: 5 of 97
- Epidemiology 280
- Molecular Biology 251
- Endocrinology, Diabetes and Metabolism 221
- Physiology 202
- Surgery 143
Countries citing papers authored by Li Wei
This map shows the geographic impact of Li Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wei more than expected).
Fields of papers citing papers by Li Wei
This network shows the impact of papers produced by Li Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wei. The network helps show where Li Wei may publish in the future.
Co-authorship network of co-authors of Li Wei
This figure shows the co-authorship network connecting the top 25 collaborators of Li Wei. A scholar is included among the top collaborators of Li Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Wei. Li Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 21 | |
| 6 | 14 | |
| 7 | 2 | |
| 8 | 14 | |
| 9 | 14 | |
| 10 | 7 | |
| 11 | 22 | |
| 12 | 39 | |
| 13 | Relationship between Anemia and Chronic Complications in Chinese Patients with Type 2 Diabetes Mellitus. | 38 |
| 14 | 2 | |
| 15 | 132 | |
| 16 | 85 | |
| 17 | 40 | |
| 18 | 8 | |
| 19 | 1 | |
| 20 | 23 |
About Li Wei
Li Wei is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Epidemiology, having authored 42 papers that have together received 930 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (221 citations), Epidemiology (280 citations) and Nephrology (57 citations). Li Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Weiping Jia, Yuqian Bao, Xuhong Hou, Junfeng Han, Jiarui Wu, Yuanyuan Xiao, Geng Zong, Hongli Chen, Chunguang Yang and Yuexing Liu. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.